Savage, D A <br/><br/>
Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Apr 1999 
 - 891-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0931-0509 
<br/><br/><label>Standard No.: </label>10.1093/ndt/14.4.891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alleles<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetic Nephropathies--genetics<br/>Glucose--metabolism<br/>Haplotypes<br/>Humans<br/>Middle Aged<br/>Receptors, Angiotensin--genetics<br/>Risk Factors